According to Medigene AG's latest financial reports the company's current EPS (TTM) is -HK$5.00. a decrease over its 2022 EPS that were of -HK$2.69.
Year | EPS | Change |
---|---|---|
2023 | -HK$5.66 | 110.67% |
2022 | -HK$2.69 | -21.45% |
2021 | -HK$3.42 | -68.01% |
2020 | -HK$10.69 | 59.95% |
2019 | -HK$6.69 | -11.87% |
2018 | -HK$7.59 | 15.96% |
2017 | -HK$6.54 | 75.86% |
2016 | -HK$3.72 | -40.03% |
2015 | -HK$6.20 | 47.29% |
2014 | -HK$4.21 | -61.32% |
2013 | -HK$10.89 | 5.39% |
2012 | -HK$10.33 | -258.78% |
2011 | HK$6.51 | -133.87% |
2010 | -HK$19.21 | -28.92% |
2009 | -HK$27.02 | -27.92% |
2008 | -HK$37.49 | -8.29% |
2007 | -HK$40.88 | 239.11% |
2006 | -HK$12.05 |